VistaGen Therapeutics Inc (VTGN) Tezkor likvidlik ko‘rsatkichi

VistaGen Therapeutics, Inc. (VTGN) grafik logotipi

Vistagen Therapeutics (VTGN) fobiya va depressiv holatlarni tezda bartaraf etish uchun burun orqali qo'llaniladigan mahsulotlarni ishlab chiqadi hamda hid bilish yo'llarini nishonga olgan holda psixofarmakologiya bozorining ulushini egallashni maqsad qilgan. Biznes neuropsychiatry sohasining himoyavoy xususiyatlariga tayanadi, bu yerda muvaffaqiyat YaIMdan ko'ra ko'proq klinik sinovlarga bog'liq. Ko'rsatkich 3.06 hisoblanadi. Ushbu narx harakati grafigi tez ta'sir qiluvchi dori vositalarining noyob klassi uchun olingan patentlar tufayli kompaniyaning barqarorligini tasdiqlaydi.

Vistagen (VTGN) - Oraliq qoplama koeffitsiyenti 04.07.2022dan 31.10.2026gacha

Vistagen Therapeutics - tahliliy kesimlar va asosiy koʻrsatkichlar (VTGN)

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi vistagen.com|VTGN - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor bahosi VistaGen Therapeutics Inc|VTGN - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Vistagen|VTGN - Biznesning balans bahosi|Bozor qiymatining balans qiymatiga nisbati vistagen.com|VTGN - Kompaniya aktivlarining umumiy hajmi
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Vistagen Therapeutics|VTGN - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati vistagen.com|VTGN - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar VistaGen Therapeutics Inc|VTGN - Uzoq muddatli qarzdorlik|Kompaniyaning qisqa muddatli qarzlari Vistagen|Tezkor likvidlik vistagen.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
VTGN - Kompaniya foydasi
Kompaniyaning dastlabki tahlili:VistaGen Therapeutics, Inc. - VTGN
Vistagen Therapeutics tayyor mahsulotlari

Vistagen Therapeutics (VTGN) kompaniyasining burun spreyi sinovlarining muvaffaqiyatli yakunlanishi natijasida obro-yuhushining ortishi uning moliyaviy barqarorligini qat'iy nazorat qilishni taqozo etadi. Tezkor koeffitsient illikvid zaxiralarni hisobga olmagan holda, faqat naqd pul va debitorlik qarzlari yordamida majburiyatlarni qoplash qobiliyatini baholaydi, bu esa GURU.Markets platformasidagi real vaqt rejimida baholash dinamikasiga ombor aktivlarini hisobga olmasdan kompaniyaning haqiqiy xavfsizlik zaxirasini aniqlash imkonini beradi.

Vistagen Therapeutics raqobatchilari

Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|Tezkor likvidlik ko‘rsatkichi RGC|Tezkor likvidlik AXSM|Tezkor likvidlik koeffitsiyenti ACAD|Oraliq qoplama koeffitsiyenti Xenon Pharmaceuticals Inc.|Tezkor likvidlik Viking Pharma VKTX|Oraliq qoplama koeffitsiyenti Supernus Corp (SUPN)|CPRX: Tezkor likvidlik ko‘rsatkichi|denalitherapeutics.com - Oraliq likvidlik koeffitsiyenti|HRMY: Tezkor likvidlik koeffitsiyenti|Biohaven Ltd (BHVN) - Tezkor likvidlik koeffitsiyenti|AMLX (Amylyx) - Tezkor likvidlik koeffitsiyenti|TRVI - Kritik likvidlik|Tezkor likvidlik koeffitsiyenti PRAX|AVXL - Shoshilinch likvidlik|Tezkor likvidlik CeriBell CBLL|PRTA: Shoshilinch likvidlik koeffitsiyenti|ALEC: Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti ANNX (Annexon Biosciences Inc.)|OMER (omeros.com) - Tezkor likvidlik ko‘rsatkichi|NGNE: Oraliq likvidlik koeffitsiyenti|ACIU (AC Immune SA) - Tezkor likvidlik koeffitsiyenti|VYGR: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti NMRA|SCLX - Shoshilinch likvidlik|Tezkor likvidlik Tevogen Bio Holdings TVGN|Oraliq qoplash koeffitsiyenti ACOG|Cognition Therapeutics - Tezkor likvidlik koeffitsiyenti|IKT - Tezkor likvidlik koeffitsiyenti|Cassava (SAVA) - Tezkor likvidlik|Kritik likvidlik koeffitsiyenti ASRT (Assertio)|COYA (Coya Therapeutics Inc) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Ovid Rx OVID|Tezkor likvidlik ko‘rsatkichi ABOS (Acumen Pharmaceuticals, Inc.)|Tezkor likvidlik koeffitsiyenti CervoMed, Inc. (CRVO)|Alterity Therapeutics Limited - Tezkor likvidlik ko‘rsatkichi|Oraliq likvidlik koeffitsiyenti CLNN (Clene Inc)|PepGen Corp - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Jupiter Neurosciences, Inc. JUNS|RLMD: Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Annovis Bio Inc|Tezkor likvidlik Grace Therapeutics Inc|Firefly Neuro (AIFF) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi KLTO (Klotho Neurosciences Inc)|Tezkor likvidlik NRSN (neurosense-tx.com)|Reviva Pharmaceuticals Holdings, Inc. - Tezkor likvidlik ko‘rsatkichi|Oraliq likvidlik koeffitsiyenti MTVA (MetaVia Inc.)|NeurAxis, Inc - Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Helius Medical (HSDT)|passagebio.com (PASG) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti NEUP|Tezkor likvidlik Minerva Neurosciences, Inc.|Shoshilinch likvidlik koeffitsiyenti ATHA (Athira Pharma Inc)|Tezkor likvidlik koeffitsiyenti ADXN|ALZN - Shoshilinch likvidlik|Cyclerion Therapeutics, Inc. - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti Protagenic Therapeutics Inc. PTIX|KTTA - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti CRGT (Cortigent, Inc.)|Avenue Therapeutics, Inc (ATXI) - Tezkor likvidlik|Shoshilinch likvidlik BrainStorm Cell Therapeutics Inc. (BCLI)|Tezkor likvidlik ko‘rsatkichi CARA|Tezkor likvidlik CHRO|Tezkor likvidlik koeffitsiyenti ELYM|Oraliq qoplama koeffitsiyenti intracellulartherapies.com|Tezkor likvidlik Longboard Pharma LBPH|Oraliq qoplama koeffitsiyenti Marinus Pharma (MRNS)|NKGN: Tezkor likvidlik ko‘rsatkichi|neurobopharma.com - Oraliq likvidlik koeffitsiyenti|SAGE: Tezkor likvidlik koeffitsiyenti|Synaptogenix Inc. (SNPX) - Tezkor likvidlik koeffitsiyenti|TRVN (Trevena, Inc) - Tezkor likvidlik koeffitsiyenti|VIGL - Kritik likvidlik|Tezkor likvidlik koeffitsiyenti WENA|CERE - Shoshilinch likvidlik